# IRulya Therapeutics Inc.: Form SC 13D, filed Nov 13, 2024

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: SC 13D
- Filed: 2024-11-13
- Accepted by EDGAR: Nov 14, 2024, 02:17 ET
- Period: not reported
- Accession: 0001193125-24-257646
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312524257646/d842349dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312524257646/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312524257646/d842349dsc13d.htm

Filed Nov 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-257646. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.